DHA for PREGnant women: is the current recommendation appropriate for women with very low intake and status?
Completed
- Conditions
- Nutritional, Metabolic, EndocrinePregnancy
- Registration Number
- ISRCTN03848493
- Lead Sponsor
- Faculty of Life Sciences and Computing, London Metropolitan University (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
Healthy women with singleton pregnancy
Exclusion Criteria
1. Pre-existing chronic medical conditions such as diabetes, high blood pressure, congenital heart disease, kidney disease, very preterm delivery
2. Sickle cell disease or hemoglobinopathies
3. History of pre-eclampsia, stillbirth or foetal death, major foetal anomaly
4. Smoking or other illegal-substance abuse
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DHA level in maternal and cord blood at delivery
- Secondary Outcome Measures
Name Time Method 1. DHA level in breast milk at postnatal week 6<br>2. Anthropometric measurement of babies at birth and postnatal week 6